• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗增殖 GPER 反向激动剂 ERα17p 与乳腺癌细胞膜的相互作用:从生物物理学到生物学。

Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology.

机构信息

Institut de Biologie Paris-Seine (IBPS), Service de Microscopie éLectronique (IBPS-SME), Sorbonne Université, CNRS, 75005 Paris, France.

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.

出版信息

Cells. 2020 Feb 15;9(2):447. doi: 10.3390/cells9020447.

DOI:10.3390/cells9020447
PMID:32075246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7072814/
Abstract

The peptide ERα17p, which corresponds to the 295-311 fragment of the hinge/AF2 domains of the human estrogen receptor α (ERα), exerts apoptosis in breast cancer cells through a mechanism involving the G protein-coupled estrogen-dependent receptor GPER. Besides this receptor-mediated mechanism, we have detected a direct interaction (Kd value in the micromolar range) of this peptide with lipid vesicles mimicking the plasma membrane of eukaryotes. The reversible and not reversible pools of interacting peptide may correspond to soluble and aggregated membrane-interacting peptide populations, respectively. By using circular dichroism (CD) spectroscopy, we have shown that the interaction of the peptide with this membrane model was associated with its folding into β sheet. A slight leakage of the 5(6)-fluorescein was also observed, indicating lipid bilayer permeability. When the peptide was incubated with living breast cancer cells at the active concentration of 10 μM, aggregates were detected at the plasma membrane under the form of spheres. This insoluble pool of peptide, which seems to result from a fibrillation process, is internalized in micrometric vacuoles under the form of fibrils, without evidence of cytotoxicity, at least at the microscopic level. This study provides new information on the interaction of ERα17p with breast cancer cell membranes as well as on its mechanism of action, with respect to direct membrane effects.

摘要

肽 ERα17p 对应于人类雌激素受体 α (ERα) 的铰链/AF2 结构域的 295-311 片段,通过涉及 G 蛋白偶联雌激素依赖性受体 GPER 的机制在乳腺癌细胞中发挥凋亡作用。除了这种受体介导的机制外,我们还检测到该肽与模拟真核生物质膜的脂质体之间的直接相互作用(Kd 值在微摩尔范围内)。这种可相互作用的肽的可逆和不可逆池可能分别对应于可溶性和聚集的膜相互作用肽群体。通过使用圆二色性 (CD) 光谱,我们已经表明,肽与该膜模型的相互作用与其折叠成 β 片层有关。还观察到 5(6)-荧光素的轻微泄漏,表明脂质双层的通透性。当肽以 10 μM 的有效浓度与活的乳腺癌细胞孵育时,在球体形式下在质膜上检测到聚集物。这种似乎源于纤维形成过程的不溶性肽池以纤维的形式在微毫米级别的空泡中内化,至少在微观水平上没有细胞毒性的证据。这项研究提供了关于 ERα17p 与乳腺癌细胞膜相互作用及其直接膜效应相关作用机制的新信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/339c139ab895/cells-09-00447-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/7719a3d2d84a/cells-09-00447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/849f3b2f0c6c/cells-09-00447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/daec0d244d55/cells-09-00447-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/264da6278d6f/cells-09-00447-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/99732b09cf36/cells-09-00447-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/0943ad3dce28/cells-09-00447-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/339c139ab895/cells-09-00447-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/7719a3d2d84a/cells-09-00447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/849f3b2f0c6c/cells-09-00447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/daec0d244d55/cells-09-00447-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/264da6278d6f/cells-09-00447-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/99732b09cf36/cells-09-00447-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/0943ad3dce28/cells-09-00447-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6492/7072814/339c139ab895/cells-09-00447-g007.jpg

相似文献

1
Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology.抗增殖 GPER 反向激动剂 ERα17p 与乳腺癌细胞膜的相互作用:从生物物理学到生物学。
Cells. 2020 Feb 15;9(2):447. doi: 10.3390/cells9020447.
2
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.肽 ERα17p 是一种 GPER 反向激动剂,可在乳腺癌细胞中发挥抗增殖作用。
Cells. 2019 Jun 14;8(6):590. doi: 10.3390/cells8060590.
3
The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice.抗肿瘤肽 ERα17p 通过 G 蛋白偶联雌激素受体在小鼠中发挥抗痛觉过敏和抗炎作用。
Front Endocrinol (Lausanne). 2021 Mar 17;12:578250. doi: 10.3389/fendo.2021.578250. eCollection 2021.
4
Improvement of the anti-proliferative activity of the peptide ERα17p in MCF-7 breast cancer cells using nanodiamonds.使用纳米金刚石提高肽ERα17p在MCF-7乳腺癌细胞中的抗增殖活性。
Ann Pharm Fr. 2019 Nov;77(6):488-495. doi: 10.1016/j.pharma.2019.07.003. Epub 2019 Sep 25.
5
ERα17p, a peptide reproducing the hinge region of the estrogen receptor α associates to biological membranes: A biophysical approach.ERα17p,一种复制雌激素受体 α 铰链区的肽与生物膜结合:一种生物物理方法。
Steroids. 2012 Aug;77(10):979-87. doi: 10.1016/j.steroids.2012.02.022. Epub 2012 Mar 8.
6
Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors.靶向具有特定的细胞膜和细胞内雌激素受体的蛋白水解嵌合体。
Mol Pharm. 2021 Mar 1;18(3):1455-1469. doi: 10.1021/acs.molpharmaceut.1c00018. Epub 2021 Feb 18.
7
Trophic effect in MCF-7 cells of ERalpha17p, a peptide corresponding to a platform regulatory motif of the estrogen receptor alpha--underlying mechanisms.雌激素受体α的平台调节基序对应的肽段ERalpha17p对MCF-7细胞的营养作用——潜在机制
J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):138-49. doi: 10.1016/j.jsbmb.2007.12.012. Epub 2007 Dec 28.
8
Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.G蛋白偶联雌激素受体GPER介导雌激素对FOXO3a的失活作用。
BMC Cancer. 2015 Oct 15;15:702. doi: 10.1186/s12885-015-1699-6.
9
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer.抗增殖 GPER 反向激动剂 ERα17p 在乳腺癌中的前景可期。
Cells. 2023 Feb 18;12(4):653. doi: 10.3390/cells12040653.
10
ER-mediated anti-tumor effects of shikonin on breast cancer.紫草素通过内质网介导的抗肿瘤作用对乳腺癌的影响。
Eur J Pharmacol. 2019 Nov 15;863:172667. doi: 10.1016/j.ejphar.2019.172667. Epub 2019 Sep 20.

引用本文的文献

1
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer.抗增殖 GPER 反向激动剂 ERα17p 在乳腺癌中的前景可期。
Cells. 2023 Feb 18;12(4):653. doi: 10.3390/cells12040653.
2
Role of the G Protein-Coupled Receptors in Cancer and Stromal Cells: From Functions to Novel Therapeutic Perspectives.G 蛋白偶联受体在癌症和基质细胞中的作用:从功能到新的治疗视角。
Cells. 2023 Feb 15;12(4):626. doi: 10.3390/cells12040626.
3
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action.

本文引用的文献

1
Improvement of the anti-proliferative activity of the peptide ERα17p in MCF-7 breast cancer cells using nanodiamonds.使用纳米金刚石提高肽ERα17p在MCF-7乳腺癌细胞中的抗增殖活性。
Ann Pharm Fr. 2019 Nov;77(6):488-495. doi: 10.1016/j.pharma.2019.07.003. Epub 2019 Sep 25.
2
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.肽 ERα17p 是一种 GPER 反向激动剂,可在乳腺癌细胞中发挥抗增殖作用。
Cells. 2019 Jun 14;8(6):590. doi: 10.3390/cells8060590.
3
Application of WST-8 based colorimetric NAD(P)H detection for quantitative dehydrogenase assays.
鉴定具有双重抗增殖和抗痛觉作用的人雌激素受体 α 四肽片段。
Sci Rep. 2023 Jan 24;13(1):1326. doi: 10.1038/s41598-023-28062-9.
4
The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice.抗肿瘤肽 ERα17p 通过 G 蛋白偶联雌激素受体在小鼠中发挥抗痛觉过敏和抗炎作用。
Front Endocrinol (Lausanne). 2021 Mar 17;12:578250. doi: 10.3389/fendo.2021.578250. eCollection 2021.
5
GPER1 and microRNA: Two Players in Breast Cancer Progression.GPER1 和 microRNA:乳腺癌进展中的两个参与者。
Int J Mol Sci. 2020 Dec 24;22(1):98. doi: 10.3390/ijms22010098.
6
Computational Approaches for the Discovery of GPER Targeting Compounds.用于发现 GPER 靶向化合物的计算方法。
Front Endocrinol (Lausanne). 2020 Aug 4;11:517. doi: 10.3389/fendo.2020.00517. eCollection 2020.
7
Does GPER Really Function as a G Protein-Coupled Estrogen Receptor ?GPER 真的是一种 G 蛋白偶联雌激素受体吗?
Front Endocrinol (Lausanne). 2020 Mar 31;11:148. doi: 10.3389/fendo.2020.00148. eCollection 2020.
基于 WST-8 的比色 NAD(P)H 检测在定量脱氢酶分析中的应用。
BMC Biochem. 2019 Apr 8;20(1):4. doi: 10.1186/s12858-019-0108-1.
4
Novel cell-penetrating-amyloid peptide conjugates preferentially kill cancer cells.新型细胞穿透性淀粉样肽缀合物优先杀死癌细胞。
Medchemcomm. 2017 Dec 5;9(1):121-130. doi: 10.1039/c7md00321h. eCollection 2018 Jan 1.
5
A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes.一种使用靶向磷脂酰丝氨酸的含硬脂胺阳离子脂质体治疗癌症的新策略。
Mol Ther Nucleic Acids. 2018 Mar 2;10:9-27. doi: 10.1016/j.omtn.2017.10.019. Epub 2017 Nov 1.
6
Phosphatidylserine: A cancer cell targeting biomarker.磷脂酰丝氨酸:一种癌症细胞靶向生物标志物。
Semin Cancer Biol. 2018 Oct;52(Pt 1):17-25. doi: 10.1016/j.semcancer.2017.08.012. Epub 2017 Sep 1.
7
Cell surface binding, uptaking and anticancer activity of L-K6, a lysine/leucine-rich peptide, on human breast cancer MCF-7 cells.赖氨酸/亮氨酸丰富肽 L-K6 与人乳腺癌 MCF-7 细胞的细胞表面结合、摄取和抗癌活性。
Sci Rep. 2017 Aug 15;7(1):8293. doi: 10.1038/s41598-017-08963-2.
8
Lipid Interactions and Organization in Complex Bilayer Membranes.复杂双层膜中的脂质相互作用与组织
Biophys J. 2016 Apr 12;110(7):1563-1573. doi: 10.1016/j.bpj.2015.12.043.
9
Understanding the molecular basis of agonist/antagonist mechanism of GPER1/GPR30 through structural and energetic analyses.通过结构和能量分析理解GPER1/GPR30激动剂/拮抗剂机制的分子基础。
J Steroid Biochem Mol Biol. 2016 Apr;158:104-116. doi: 10.1016/j.jsbmb.2016.01.001. Epub 2016 Jan 6.
10
Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands.用于发现选择性GPER配体的大分子建模与对接模拟
AAPS J. 2016 Jan;18(1):41-6. doi: 10.1208/s12248-015-9844-3. Epub 2015 Nov 16.